Halozyme wins Dutch court order to halt Merck Keytruda in eight markets
Halozyme said a Dutch patent court ordered Merck to halt manufacture and sale of injectable Keytruda in eight European markets.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.